The altered DNA methylation pattern and its implications in liver cancer

Cell Research

Volumn 15, Issue 4, 2005, Pages 272-280

  Zhu, Jing De ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA methylation; Epigenetics; Liver cancer; Tumor staging and classification

Indexed keywords

ANIMAL; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; LIVER NEOPLASMS;

EID: 24344471764     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290296     Document Type: Review

References (49)

1. Fazzari MJ, Greally JM. Epigenomics: beyond CpG islands. Nat Rev Genet 2004; 5:446-55.
2. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4:143-53.
3. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992; 69:915-26.
4. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99:247-57.
5. Esteller M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 2000; 36:2294-300.
6. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60:2368-71.
7. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001; 61:4689-92.
8. Chen RZ, Pettersson U, Beard C, et al. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395:89-93.
9. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455.
10. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
11. Esteller M, Fraga MF, Guo M, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001; 10:3001-7.
12. Oommen AM, Griffin JB, Sarath G, Zempleni J. Roles for nutrients in epigenetic events. J Nutr Biochem 2005; 16:74-7.
13. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 Suppl:245-54.
14. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3:662-73.
15. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 2000; 249:101-18.
16. Hochedlinger K, Jaenisch R. Nuclear transplantation: lessons from frogs and mice. Curr Opin Cell Biol 2002; 14:741-8.
17. Dunn BK. Hypomethylation: one side of a larger picture. Ann N Y Acad Sci 2003; 983:28-42.
18. Esteller M. Dormant hypermethylated tumor suppressor genes: questions and answers. J Pathol 2005; 205:172-80.
19. Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149:76-82, 84-6, 88 passim.
20. Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification. Cancer 2004; 100:1-5.
21. Lane DP. p53 and human cancers. Br Med Bull 1994; 50:582-99.
22. Neibergs HL, Hein DW, Spratt JS. Genetic profiling of colon cancer. J Surg Oncol 2002; 80:204-13.
23. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23:29-39.
24. Bosch F, Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E. Eds. Liver Cancer, Churchill Livingstone: New York 1997:13-28.
25. Yu J, Zhang H, Gu J, et al. Methylation profiling of thirty four promoter-CpG islands and concordant methylation behaviors of sixteen genes that may contribute to carcinogenesis of malignant glioma. BMC Cancer 2004; 4:65.
26. Yu J, Zhang HY, Ma ZZ, et al. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res 2003; 13:319-33.
27. Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002; 2:29.
28. Yang Z, Shang Z, Yu J, et al. The methylation profiles of the promoter CpG island of nine tumor associated genes correlate with their expression in three lung cancer cell lines. Tumor 2004; 11:216-22 (In Chinese).
29. Xu X, Yu J, Zhang H, et al. Methylation profile of the promoter CpG islands of thirty one genes that may contribute to carcinogenesis of the colorectal cancer. World J Gastroenterol 2004; 10:3441-54.
30. Li J, Fei Q, Yu J, et al. Correlation between methylation profile of promoter CpG islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Chinese Journal of Cancer 2004; 23:985-91 (In Chinese).
31. Ding S, Gong B, Yu J, et al. Methylation profile of the promoter CpG islands of fourteen "drug-resistance" genes in hepatocellular carcinoma. World J Gastroenterol 2004; 10:3443-40.
32. Zhang K, Siino JS, Jones PR, et al. A mass spectrometric "Western blot" to evaluate the correlations between histone methylation and histone acetylation. Proteomics 2004; 4:3765-75.
33. Zhao Y, Yang J, Zhu JD. The interaction of Sp1 transcription factor with two Erg-1 sies at -71 /-48 upstream contribute significantly to the promoter activity of the HE4 gene in tumor cells. Tumor 2004; 24:517-25 (In Chinese).
34. Cai L, Zhu JD. The tumor-selective over-expression of the human Hsp70 gene is attributed to the aberrant controls at both initiation and elongation levels of transcription. Cell Res 2003; 13:93-109.
35. Guo JY, Xu J, Mao Q, et al. The promoter analysis of the human C17or f25 gene, a novel chromosome 17p13.3 gene. Cell Res 2002; 12:339-52.
36. Xu J, Zhu J, Ni M, et al. The ATF/CREB site is the key element for transcription of the human RNA methyltransferase like 1 (RNMTL1) gene, a newly discovered 17p13.3 gene. Cell Res 2002; 12:177-97.
37. Zhang J, Yu J, Gu J, et al. A novel protein-DNA interaction involved with the CpG dinucleotide at -30 upstream is linked to the DNA methylation mediated transcription silencing of the MAGE-A1 gene. Cell Res 2004; 14:283-94.
38. Jones PA. An epigenetic approach for finding tumor suppressors. Cell Cycle 2003; 2:25-6.
39. Markl ID, Cheng J, Liang G, et al. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res 2001; 61:5875-84.
40. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6.
41. Agrawal R, Imielinski T, Swami A. Mining association rules between sets of items in large databases. ACM SIGMOD Conference. ACM SIGMOD Conference 1993:207-16.
42. Eckhardt F, Beck S, Gut IG, Berlin K. Future potential of the Human Epigenome Project. Expert Rev Mol Diagn 2004; 4:609-18.
43. Novik KL, Nimmrich I, Gene B, et al. Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol 2002; 4:111-28.
44. Rakyan VK, Hildmann T, Novik KL, et al. DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2004; 2:e405.
45. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev 1995; 5:309-14.
46. Ioshikhes IP, Zhang MQ. Large-scale human promoter mapping using CpG islands. Nat Genet 2000; 26:61-3.
47. Takai D, Jones PA. The CpG island searcher: a new WWW resource. In Silico Biol 2003; 3:235-40.
48. Cross SH, Charlton JA, Nan X, Bird AP. Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994; 6:236-44.
49. Meehan RR, Lewis JD, Bird AP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 1992; 20:5085-92.